PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-28848.54
Negative P/E while Healthcare median is -0.12. Seth Klarman would scrutinize path to profitability versus peers.
No Data
No Data available this quarter, please select a different quarter.
-2727.48
Negative equity while Healthcare median P/B is 2.26. Seth Klarman would investigate balance sheet restructuring potential.
-14341.85
Negative FCF while Healthcare median P/FCF is -13.39. Seth Klarman would investigate cash flow improvement potential.
-14341.85
Negative operating cash flow while Healthcare median P/OCF is 0.00. Seth Klarman would investigate operational improvement potential.
-2727.48
Negative fair value while Healthcare median is 2.26. Seth Klarman would investigate valuation model issues.
-0.00%
Negative earnings while Healthcare median yield is -0.03%. Seth Klarman would investigate path to profitability.
-0.01%
Negative FCF while Healthcare median yield is -0.19%. Seth Klarman would investigate cash flow improvement potential.